Effectiveness and Cost-Effectiveness of a Tele-Rehabilitation Program in the Treatment of Chronic Musculoskeletal Pain
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Chronic Pain
- Sponsor
- Universidade Cidade de Sao Paulo
- Enrollment
- 160
- Locations
- 1
- Primary Endpoint
- Pain Intensity at post-treatment follow-up
- Last Updated
- 6 years ago
Overview
Brief Summary
The aim of this clinical trial is to develop and test the effectiveness and cost-effectiveness of an internet-based self-management program based on pain education and exercise for people with chronic musculoskeletal pain.
Detailed Description
Chronic pain is a major burden on the individual and society. It is estimated that about one third of the adult population worldwide suffer from chronic pain, with higher prevalence rates reported for low-income countries. Internet-based self-management programs have grown with the development of new technologies and have been extensively used for delivering healthcare in many areas. However, there is still little research on the development and testing of remotely-delivered programs for the management of chronic musculoskeletal pain, especially in low and mid-income countries. The aim of this clinical trial is to develop and test the effectiveness and cost-effectiveness of an internet-based self-management program based on pain education and exercise for people with chronic musculoskeletal pain.
Investigators
Dr Bruno Saragiotto
Assistant Professor
Universidade Cidade de Sao Paulo
Eligibility Criteria
Inclusion Criteria
- •Aged between 18 and 60 years
- •Seeking treatment for any chronic musculoskeletal pain of at least 3 points in a 0 to 10 Pain Numerical Rating Scale
- •Able to read and understand Portuguese
- •With internet access.
- •Chronic Pain will be defined as pain lasting more than 12 weeks.
Exclusion Criteria
- •Present neurological symptoms (nerve root compromise, or sensation deficits)
- •Present serious spinal pathologies (e.g., fracture, tumor, inflammatory, autoimmune, and infectious diseases)
- •Present serious cardiovascular and metabolic diseases (e.g., coronary heart disease, cardiac insufficiency, decompensated diabetes)
- •Recent orthopaedic surgery (over the last 12 months)
- •Scheduled to undergo surgery in the next 6 months, or pregnancy
- •If have any contraindication to exercise
- •We will perform a pre-screening for physical activity participation at baseline using the Physical Activity Readiness Questionnaire (PAR-Q) Portuguese version to rule out any contraindication to participate in physical activity.
Outcomes
Primary Outcomes
Pain Intensity at post-treatment follow-up
Time Frame: Post-treatment follow-up (8 weeks)
The primary outcome will be pain intensity measured using the Pain Numerical Rating Scale, a numerical scale of 11 domains, where 0 indicates no pain and 10 indicates maximum pain intensity.
Secondary Outcomes
- Pain intensity at 6 months and 12 months follow-up(6 months and 12 months follow-up)
- Function(The outcome will be evaluated after the treatment period (8 weeks), after 6 months of randomization and after 12 months of randomization of each subject.)
- Health-Related Quality of Life(The outcome will be evaluated after the treatment period (8 weeks), after 6 months of randomization and after 12 months of randomization of each subject.)
- Kinesiophobia(The outcome will be evaluated after the treatment period (8 weeks), after 6 months of randomization and after 12 months of randomization of each subject.)
- Global Perceived Effect(The outcome will be evaluated after the treatment period (8 weeks), after 6 months of randomization and after 12 months of randomization of each subject.)
- Anxiety and Depression(The outcome will be evaluated after the treatment period (8 weeks), after 6 months of randomization and after 12 months of randomization of each subject.)
- Pain Catastrophisation(The outcome will be evaluated after the treatment period (8 weeks), after 6 months of randomization and after 12 months of randomization of each subject.)
- Pain-related Attitudes and Beliefs(The outcome will be evaluated after the treatment period (8 weeks), after 6 months of randomization and after 12 months of randomization of each subject.)
- Self-efficacy(The outcome will be evaluated after the treatment period (8 weeks), after 6 months of randomization and after 12 months of randomization of each subject.)
- Adverse Effects(The outcome will be evaluated after the treatment period (8 weeks), after 6 months of randomization and after 12 months of randomization of each subject.)